We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
QFinds is a purpose-built hiring tool that enables employers to easily and efficiently pre-screen candidates, conduct interviews and generate employment contracts. The company asserts that it is a UK government vetted 'Kickstart Scheme' representative and can get small businesses grants to hire interns having already processed over 100 job applications. QFinds claims that its app has been downloaded 2 million+ times garnering 24,000 reviews averaging 4.8/5 stars. QFinds also points out that bad hirings cost the UK up to £6.7 billion in turnover, productivity, and training. It seeks to change this and disrupt the £39 billion recruitment market. The company has partnered with notable entities like University College London, Kings College London and Brunel University London, intending to use them as strategic partners to increase job seekers signing up to and using its app. QFinds will use the investment to grow its business across different verticals.

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £222,866
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Milbotix, a healthtech start-up, supported by the Alzheimer's Society and the UK Dementia Research Institute, is driven by its innovative product SmartSocks™. This wearable technology aims to assist individuals with dementia facing communication challenges and their caregivers. Globally, the number of people with dementia is increasing significantly, reaching 78 million by 2030 and 139 million by 2050. Half of those diagnosed with dementia encounter challenging behavioral symptoms due to distress. Early distress management not only enhances well-being but also helps prevent escalating behavioral issues. SmartSocks™ utilize sensors and artificial intelligence to notify dementia caregivers about early signs of pain and anxiety in their patients.
days to go: Expired investment: £220,780
PiP iT powers international cash transactions. The PiP iT solution is a B2B plaform, the first in the world that enables companies to accept cash payments across borders. The process works by the consumer selecting a bill they want to pay in their home country.
days to go: Expired investment: £173,820
A financial management software application for consumers to view everything from credit files and bank accounts, to vouchers and cashbacks. Score Genius aims to launch an Alpha version of their product at the end of 2018, with a public release planned for March 2019. The service will offer users the ability to monitor their credit files and perform transactions on their bank accounts and credits, as Open Banking will be integrated into the platform. Score Genius is near completion of negotiations with large technological partners. Investments will used to market the platform and further develop features and functions, ready for the public release in 2019. Revenue streams will be comprised of advertisements, redeeming vouchers and users looking to switch their energy.
days to go: Expired investment: £144,920
&SISTERS is a femcare company offering products that are hypoallergenic, pH-neutral and free from chlorine, pesticides & perfumes. It has sold 225,000+ certified organic cotton period products, directly to 300+ customers. The company has many listed retailers including Feel Unique, Farmdrop and Triyoga and exports to many countries including Asia and Europe. In January 2020, &SISTERS is planning to launch a new paper-wrapped naked tampon®. With the proceeds, the company will expand the product range, expand the team, raise awareness and accelerate sales.
days to go: Expired investment: £199,630
Pioneering medical device company with patented technologies in the "key hole" surgery market 
days to go: Expired investment: £600,083
MyFirstUK is a car insurance platform for first time driver. It aims to offer young people the perfect cover at the right price and also provide them with all of the guidance they need to make an informed decision. 
days to go: Expired investment: £61,920
Central Plains Group (CPG) is a farming company with a vision to build an integrated zero-waste farming and processing operation to supply the rapidly expanding starch, bioplastics and plant protein markets globally. It aims to be a contender in the aforementioned markets that are expected to be worth more than $30 billion by 2026. CPG previously built and ran a large-scale farming operation in Eastern Europe for over 25 years, over 200,000 hectares of land and earning more than $250 million in profits. It aspires to take things further by promoting sustainable farming and contributing to the zero-waste bio-economy. CPG established its core feedstock farming platform in Ukraine achieving over £3 million worth of revenue with a net profit of £300,000 having supplied 11,000 tonnes of crisping potatoes to Pepsico and Ukraine Supermarkets. CPG will use the investment to actualise the construction of a 15 tonne/hour starch production facility powered by a green energy source.
days to go: Expired investment: £3,031,685
Monva is a financial technology platform that uses Artificial Intelligence (AI) to revolutionise the price comparison experience and personalise customer offers. It argues that only 38% of people in the UK trust Price Comparison Websites (PCWs) with the majority being wary of such entities. Monva aims to change that. Its AI Chatbot ‘Mo’ helps customers save time by suggesting search queries, highlighting key information to assist in making switching decisions, and providing alerts to new automated offers. The company has raised £625,000 in 2020 from DBW, Angels and crowdfunding sites. It was also overfunded by >200%. It aims to become a contender in the price comparison market valued at £2.8 billion. It will use the investment to continue building its smart comparison technology, secure commercial partnerships, and grow its marketing activity.
days to go: Expired investment: £451,905
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph